Physician

Alberto Comas Espinal, M.D.

According to 2025 Medicare claims, Alberto Espinal, M.D. (NPI: 1679502785) practices general practice in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. Espinal uses personal NPI as billing NPI and primary practice location at 10033-4831. Espinal is affiliated with the SOMOS ACO (ACO ID: A4577), participating under the MSSP model.

Espinal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 46 traditional Medicare patients, billed 301 HCPCS/CPT codes, and received $14,695 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,988 prescription claims across 810 beneficiaries totaling $1,640,436 in drug costs, led by Ozempic (Semaglutide). 2019 DME data shows 12 claims. Open Payments data shows 4 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $35,117 to $14,695. In contrast, Part D prescription costs have risen steadily, from $909,557 to $1,640,436. For DME billing, this smaller-volume category did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	109	570	$35,117
2016	122	897	$38,653
2017	112	830	$32,767
2018	105	689	$26,179
2019	114	790	$32,576
2020	79	667	$29,513
2021	56	410	$21,488
2022	52	377	$20,381
2023	47	374	$20,824
2024	46	301	$14,695

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	565	12,477	$909,557
2016	626	15,857	$1,070,731
2017	567	13,566	$758,345
2018	603	14,900	$860,730
2019	628	14,476	$1,001,564
2020	712	13,266	$1,136,286
2021	694	11,541	$1,178,076
2022	721	12,208	$1,349,314
2023	784	13,829	$1,705,144
2024	810	13,988	$1,640,436

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	35	$404
2016	31	74	$23,539
2017	N/R	14	$163
2018	N/R	N/R	N/R
2019	N/R	12	$178
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	30	47	$84
99442	Telephone medical discussion with physician, 11-20 minutes	23	37	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	29	49	$66
36415	Insertion of needle into vein for collection of blood sample	28	31	$9
82947	Blood glucose (sugar) level	21	30	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	170	6,120	$167,706
Januvia	Sitagliptin Phosphate	161	8,970	$158,450
Vascepa	Icosapent Ethyl	273	20,040	$111,866
Janumet	Sitagliptin Phos/Metformin Hcl	98	6,000	$105,857
Farxiga	Dapagliflozin Propanediol	107	5,478	$98,046

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$73	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

General practice providers in the New York-Jersey City-White Plains, NY-NJ market
Providers within practice ZIP code 10033-4831
Providers whose plurality patient county is New York, NY
Providers in New York affiliated with SOMOS ACO (MSSP)

FAQ

What Medicare data is available for Alberto Comas Espinal, M.D.?

Tedicare shows public-source Medicare data for Alberto Comas Espinal, M.D. (NPI 1679502785), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto Comas Espinal, M.D. have ACO affiliation data?

Alberto Comas Espinal, M.D. is shown with ACO affiliation data for SOMOS ACO (MSSP, ACO ID A4577).

What billing organization is linked to Alberto Comas Espinal, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Alberto Comas Espinal, M.D. have Open Payments data?

Alberto Comas Espinal, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.